Drugs / Lyophilized fecal microbiota
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05327790 | Jun 2022 → Mar 2027 expected | ulcerative colitis | University of Alberta | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lyophilized fecal microbiota | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05327790 ↗ |
| Known as | LFMT | “Lyophilized fecal microbiota (LFMT)” NCT05327790 ↗ |